Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Cadinha & Co. LLC

Cadinha & Co. LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% during the second quarter, Holdings Channel.com reports. The fund owned 57,841 shares of the medical equipment provider’s stock after purchasing an additional 594 shares during the quarter. Intuitive Surgical accounts for 4.8% of Cadinha & Co. LLC’s holdings, making the stock its 5th largest holding. Cadinha & Co. LLC’s holdings in Intuitive Surgical were worth $25,731,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in ISRG. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical during the second quarter worth approximately $26,000. Creekmur Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares in the last quarter. Delos Wealth Advisors LLC boosted its position in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the period. LRI Investments LLC acquired a new stake in Intuitive Surgical in the 1st quarter valued at $30,000. Finally, Able Wealth Management LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at about $28,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.1 %

Shares of NASDAQ ISRG opened at $492.63 on Friday. The stock has a market capitalization of $175.06 billion, a P/E ratio of 88.92, a PEG ratio of 5.43 and a beta of 1.39. The stock’s 50 day moving average price is $454.69 and its two-hundred day moving average price is $414.46. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $493.97.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. The business had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business’s revenue was up 14.5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.18 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ISRG. Truist Financial upped their target price on Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a research report on Tuesday, July 16th. JPMorgan Chase & Co. upped their price target on Intuitive Surgical from $475.00 to $495.00 and gave the stock an “overweight” rating in a report on Friday, July 19th. Morgan Stanley lifted their price objective on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. BTIG Research upped their target price on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research note on Wednesday. Finally, Barclays raised their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $446.45.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Intuitive Surgical news, EVP Myriam Curet sold 2,818 shares of the firm’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $1,291,010.34. Following the sale, the executive vice president now directly owns 298 shares in the company, valued at $136,522.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. The disclosure for this sale can be found here. In the last three months, insiders have sold 55,552 shares of company stock worth $26,281,657. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.